tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

PSTV Stock Latest News

Plus Therapeutics to Present at the Gordon Research Conference Radionuclide Theranostics for the Management of Cancer
Press ReleasesPlus Therapeutics to Present at the Gordon Research Conference Radionuclide Theranostics for the Management of Cancer
16d ago
PSTV
Plus Therapeutics CMO Dr. LaFrance Resignation Announced
PremiumCompany Announcements
Plus Therapeutics CMO Dr. LaFrance Resignation Announced
1M ago
8K
PSTV
Plus Therapeutics files to sell 10.77M shares of common stock for holders
PremiumThe Fly
Plus Therapeutics files to sell 10.77M shares of common stock for holders
1M ago
PSTV
Plus Therapeutics Expands Management Team and Reports $3.3M Advance Payment from CPRIT
PremiumPress Releases
Plus Therapeutics Expands Management Team and Reports $3.3M Advance Payment from CPRIT
1M ago
PSTV
Plus Therapeutics appoints Fuller as VP, reports $3.3M advance payment
PremiumThe Fly
Plus Therapeutics appoints Fuller as VP, reports $3.3M advance payment
1M ago
PSTV
Y-mAbs Therapeutics appoints LaFrance as Chief Development Officer
PremiumThe FlyY-mAbs Therapeutics appoints LaFrance as Chief Development Officer
1M ago
PSTV
YMAB
Plus Therapeutics Secures Loan to Terminate Debt and Regain Freedom
PremiumCompany Announcements
Plus Therapeutics Secures Loan to Terminate Debt and Regain Freedom
1M ago
8K
PSTV
Plus Therapeutics Announces New Employment Inducement Grants
PremiumPress Releases
Plus Therapeutics Announces New Employment Inducement Grants
2M ago
PSTV
Plus Therapeutics at Risk of Nasdaq Delisting: A Dive into Compliance Challenges and Potential Market Impact
PremiumCompany Announcements
Plus Therapeutics at Risk of Nasdaq Delisting: A Dive into Compliance Challenges and Potential Market Impact
2M ago
PSTV
Plus Therapeutics reports Q1 EPS (75c), consensus ($1.09)
PremiumThe Fly
Plus Therapeutics reports Q1 EPS (75c), consensus ($1.09)
2M ago
PSTV
Plus Therapeutics to Announce First Quarter Financial Results and Host Conference Call on May 15, 2024
PremiumPress Releases
Plus Therapeutics to Announce First Quarter Financial Results and Host Conference Call on May 15, 2024
2M ago
PSTV
Plus Therapeutics Provides Highlights Regarding Leptomeningeal Metastases Acquisition and Topline Clinical Trial Data on the FORESEE Trial
PremiumPress Releases
Plus Therapeutics Provides Highlights Regarding Leptomeningeal Metastases Acquisition and Topline Clinical Trial Data on the FORESEE Trial
2M ago
PSTV
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
2M ago
AIM
BCRX
Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE Trial
PremiumPress Releases
Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE Trial
2M ago
PSTV
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
ADMA
BCRX
Plus Therapeutics announces up to $18M private placement financing
PremiumThe Fly
Plus Therapeutics announces up to $18M private placement financing
2M ago
PSTV
Plus Therapeutics Announces Private Placement Financing of up to $18 Million
PremiumPress Releases
Plus Therapeutics Announces Private Placement Financing of up to $18 Million
2M ago
PSTV
Plus Therapeutics receives $3M award recommendation from U.S. DOD
PremiumThe Fly
Plus Therapeutics receives $3M award recommendation from U.S. DOD
3M ago
PSTV
Is PSTV a Buy, Before Earnings?
PremiumPre-Earnings
Is PSTV a Buy, Before Earnings?
3M ago
PSTV
Plus Therapeutics appoints Andrew Brenner, Barbara Blouw to management team
PremiumThe FlyPlus Therapeutics appoints Andrew Brenner, Barbara Blouw to management team
3M ago
PSTV
Neuro-Oncologist Andrew Brenner, M.D., Ph.D. and Barbara Blouw, Ph.D. Join Plus’ Management Team
PremiumPress Releases
Neuro-Oncologist Andrew Brenner, M.D., Ph.D. and Barbara Blouw, Ph.D. Join Plus’ Management Team
3M ago
PSTV
Plus Therapeutics announces validation, implementation of CSF-01 diagnostic
PremiumThe Fly
Plus Therapeutics announces validation, implementation of CSF-01 diagnostic
4M ago
PSTV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >